Home

Biotech

Broadband

B2B Internet

Europe 2001

Internet

Internet 
Architecture

Internet 
Infrastructure

Market 2000+

Oil Services

Pharmaceutical

Regional Bank

Retail

Semiconductor

Software

Telecom

Utilities

Wireless
Cephalon Inc (NASDAQ GS:CEPH)11:12 AM ET
most recent headlinesmore headlines:       
THURSDAY, FEBRUARY 04, 2010
10:00 AMBioClinica Inks Multi-Year Outsourcing Deal with Leading Biopharmaceutical Company - BusinessWire
MONDAY, FEBRUARY 01, 2010
7:00 AMCephalon, Inc. Announces Agreement to Acquire Mepha AG - PR Newswire
THURSDAY, JANUARY 28, 2010
8:00 AMCephalon Announces Executive Leadership Changes - PR Newswire
MONDAY, JANUARY 11, 2010
7:30 AMMylan Confirms First-to-File Patent Challenge Relating to Sleep-Disorder Drug Nuvigil(R) - PR Newswire
6:09 AMCephalon Inc reports resignation of executive VP of Worldwide Pharmaceutical Operations - M2
FRIDAY, JANUARY 08, 2010
3:00 PMCephalon Fourth Quarter & Full Year 2009 Earnings Conference Call Thursday, February 11, 2010 at 5:00 p.m. EST - PR Newswire
9:00 AMCephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position - PR Newswire
WEDNESDAY, JANUARY 06, 2010
11:06 AMWatson Files FDA Application for Generic Nuvigil(R) - PR Newswire
MONDAY, DECEMBER 21, 2009
4:30 PMCephalon Provides Update on Regulatory Review of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder - PR Newswire
THURSDAY, DECEMBER 17, 2009
4:05 PMAMAG Pharmaceuticals, Inc. Announces Appointment of Lesley Russell to Board of Directors - BusinessWire


Quotes delayed at least 15 minutes. Market data provided by Interactive Data.
Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

HOLDRS Defined |  HOLDRS Outstanding  |  FAQ  |  Proxies by email  |  Investment Strategies
Spin-Offs & Changes  |  Current Trading  |  Download a Prospectus  |  Cost Basis Calculator  |  Site Map

Merrill Lynch, Pierce, Fenner & Smith Incorporated is a registered broker-dealer and a wholly-owned subsidiary of Bank of America Corporation.
Securities Products: Are Not FDIC Insured • Are Not Bank Guaranteed • May Lose Value.

The information in this Internet site is directed at, and is intended for distribution to, and for use by, persons in the U.S. only, and is not intended for distribution to or use by any person in any other jurisdiction. Merrill Lynch does not warrant the accuracy or completeness of any price, tax, cost basis, or other information on this site, or any investment, tax or other benefits associated with HOLDRS.

The information on HOLDRSSM contained in this Internet site is solely for informational purposes and does not constitute either an offer to sell or the solicitation of an offer to buy HOLDRS. This information on HOLDRS is not, and is not intended to be, a complete discussion of all material information you should know about HOLDRS. If you are considering whether to purchase a HOLDRS security, you should carefully read the relevant prospectus prior to making a purchase. You should not rely on the information contained in this Internet site. Please view Terms of Use and Legal Notices for additional important legal information and the terms and conditions governing your use of this site.

U.S. Patent Pending.
HOLDRS and HOLding Company Depositary ReceiptS are service marks of Merrill Lynch & Co., Inc.

© Copyright 2000, Merrill Lynch, Pierce, Fenner & Smith Incorporated. Member, Securities Investor Protection Corporation (SIPC). All rights reserved.